Comparative Efficacy of Topical Finasteride (0.25%) in Combination with Minoxidil (5%) Against 5% Minoxidil or 0.25% Finasteride Alone in Male Androgenetic Alopecia
International Journal of Trichology · 2023-03 · 15 (2) · 56-62
DOI: 10.4103/ijt.ijt_72_22 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Trichology, 2023-03. Verfasst von Apoorva V Bharadwaj und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and STD, Lady Hardinge Medical College, New Delhi, India. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Androgenetic alopecia (AGA) is the most common cause of hair loss in males which remains a therapeutic challenge.
Objectives
To compare the efficacy of topical 5% minoxidil and 0.25% finasteride combination (MNF) over 5% minoxidil (MNX) or 0.25% finasteride (FNS) alone by assessing hair count, physician assessment score (PAS), and patient satisfaction score (PSS). Materials and Methods: Pilot randomized open-label study where 60 male patients with AGA ≥ III grade were randomized into three treatment groups and evaluated over 24 weeks. Improvement in hair count was assessed manually using dermoscopy. Global photographs were used to assess PAS. Side effects were evaluated using relevant laboratory investigations.
Results
At the 12 th and 24 th week, all three groups showed significant improvement in total hair density as compared to baseline ( P < 0.001). None of the groups was superior to the other ( P > 0.05) at the 12 th week but at 24 th week, MNF was comparatively superior ( P < 0.02). At the 12 th week and 24 th week, all three groups showed significant improvement in terminal hair density as compared to baseline ( P < 0.001). In the 12 th week, MNF was comparatively superior ( P = 0.028) and at the 24 th week, MNF was comparatively superior ( P < 0.02). PAS and PSS were significantly better with MNF and MNX compared to FNS ( P < 0.004). Side effects such as scaling and itching were reported with MNF and MNX.
Conclusion
Topical minoxidil 5% and finasteride 0.25% had an overall better efficacy compared to monotherapy without significant side effects.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology and STD, Lady Hardinge Medical College, New Delhi, India.
- Department of Pharmacology, Lady Hardinge Medical College, New Delhi, India.
- Department of Biochemistry, Lady Hardinge Medical College, New Delhi, India.
Zitieren
APA
Bharadwaj, A. V., Mendiratta, V., Rehan, H. S., & Tripathi, S. (2023). Comparative Efficacy of Topical Finasteride (0.25%) in Combination with Minoxidil (5%) Against 5% Minoxidil or 0.25% Finasteride Alone in Male Androgenetic Alopecia. International Journal of Trichology, 15(2), 56-62. https://doi.org/10.4103/ijt.ijt_72_22
Vancouver
Bharadwaj AV, Mendiratta V, Rehan HS, Tripathi S. Comparative Efficacy of Topical Finasteride (0.25%) in Combination with Minoxidil (5%) Against 5% Minoxidil or 0.25% Finasteride Alone in Male Androgenetic Alopecia. International Journal of Trichology. 2023;15(2):56-62. doi:10.4103/ijt.ijt_72_22
BibTeX
@article{Bharadwaj2023,
author = {Bharadwaj, Apoorva V and Mendiratta, Vibhu and Rehan, Harmeet Singh and Tripathi, Smita},
title = {Comparative Efficacy of Topical Finasteride (0.25%) in Combination with Minoxidil (5%) Against 5% Minoxidil or 0.25% Finasteride Alone in Male Androgenetic Alopecia},
journal = {International Journal of Trichology},
year = {2023},
volume = {15},
number = {2},
pages = {56--62},
doi = {10.4103/ijt.ijt_72_22}
}
EUVIMED